Cadila Healthcare informs about press release

12 Nov 2018 Evaluate

Cadila Healthcare has informed about submission of a copy of press release dated November 12, 2018 titled ‘Zydus receives final approval from the USFDA for Nystatin and Triamcinolone Acetonide Ointment USP’. 

The above information is a part of company’s filings submitted to BSE.

Zydus Lifesciences Share Price

890.50 -2.95 (-0.33%)
28-Jan-2026 09:39 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1632.35
Dr. Reddys Lab 1233.60
Cipla 1314.10
Zydus Lifesciences 890.50
Lupin 2142.60
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×